Impact of SARS-CoV-2/COVID-19 on Provision of Medical Care to Patients With Systemic Autoimmune Rheumatic Disease and the Practice of Rheumatology

Simple item page
dc.contributor.authorBankole, Adegbenga A.en
dc.contributor.authorNwaonu, Janeen
dc.contributor.authorSaeed, Jahanzeben
dc.date.accessioned2023-03-23T13:25:48Zen
dc.date.available2023-03-23T13:25:48Zen
dc.date.issued2023-02-24en
dc.date.updated2023-03-22T20:47:06Zen
dc.description.abstractThe SARS-CoV-2 pandemic has had a significant impact on the healthcare field that resulted in changes to the way safe and effective medical care is delivered. The effects range from service disruption including ambulatory clinic closure due to both patient and provider concerns, to lack of capacity in hospital services. In rheumatology, there were other effects including viral infection-related autoantibody production, concerns about the use of systemic immunosuppression in the presence of an infectious pandemic and even concerns for viral infection-induced flares of rheumatic disease. Coronavirus disease 2019 (COVID-19) led to the rapid adoption of innovative technologies that permitted the introduction and increased use of telemedicine via a number of platforms. Rapid discoveries and innovations led to the development of diagnostic and therapeutic agents in the management of COVID-19. Scientific advancement and discoveries around COVID-19 infection, symptoms, autoantibody production, chronic sequela and the repurposing of rheumatic immunosuppressive agents led to improved survival and an expanded role for the rheumatologist. Rheumatologists may sometimes be involved in the diagnosis and management of the hospitalized COVID- 19 patient. In the ambulatory clinic, a rheumatologist also helps to differentiate between symptoms of long COVID and those of systemic autoimmune rheumatic disease (SARD). Rheumatologists must also grapple with the concerns related to immunosuppressive therapy and the risk of COVID-19 infections. In addition, there are concerns around vaccine effectiveness in people with SARD and those on immunosuppressive medications. Although the SARS-CoV-2 pandemic and the effects on healthcare resulted in difficulties, both patients and providers have risen to the challenge. The long-term outcome of COVID-19 for the medical system and rheumatologists in particular is not yet fully understood and will need further study. This review concentrates on the changing role of the rheumatologists, improved understanding of rheumatic disease and immunosuppressive therapies in the wake of the pandemic and how this has led to an improvement in the care of patients with COVID-19.en
dc.description.versionPublished versionen
dc.format.mimetypeapplication/pdfen
dc.identifier.doihttps://doi.org/10.7759/cureus.35402en
dc.identifier.issn2168-8184en
dc.identifier.issue2en
dc.identifier.orcidBankole, Adegbenga [0000-0001-6464-5367]en
dc.identifier.urihttp://hdl.handle.net/10919/114156en
dc.identifier.volume15en
dc.language.isoenen
dc.publisherSpringeren
dc.rightsCreative Commons Attribution 4.0 Internationalen
dc.rights.urihttp://creativecommons.org/licenses/by/4.0/en
dc.subjectArthritisen
dc.subjectClinical researchen
dc.subjectPreventionen
dc.subjectHealth servicesen
dc.subjectInfectious diseasesen
dc.subjectEmerging Infectious Diseasesen
dc.subjectAutoimmune Diseaseen
dc.subjectInfectionen
dc.subjectInflammatory and immune systemen
dc.titleImpact of SARS-CoV-2/COVID-19 on Provision of Medical Care to Patients With Systemic Autoimmune Rheumatic Disease and the Practice of Rheumatologyen
dc.title.serialCureusen
dc.typeArticle - Refereeden
dc.type.dcmitypeTexten
pubs.organisational-group/Virginia Techen
pubs.organisational-group/Virginia Tech/VT Carilion School of Medicineen
pubs.organisational-group/Virginia Tech/VT Carilion School of Medicine/Internal Medicineen
pubs.organisational-group/Virginia Tech/VT Carilion School of Medicine/Internal Medicine/Rheumatologyen
pubs.organisational-group/Virginia Tech/VT Carilion School of Medicine/TEACH Membersen

Files

Original bundle
Now showing 1 - 1 of 1
Thumbnail Image
Name:
20230224-31470-16n4j2k.pdf
Size:
372.89 KB
Format:
Adobe Portable Document Format
Description:
Published version
Download

Collections

All Faculty Deposits
Scholarly Works, Virginia Tech Carilion School of Medicine (VTCSOM)